The grey market premium of the Goldline Pharmaceutical IPO, day by day, against the ₹43 upper price band. Last figure from 19 May 2026.
The GMP of the Goldline Pharmaceutical IPO started at ₹0 on 7 May 2026 and ended ₹15 before listing, up ₹15 over 13 days.
It peaked at ₹25 on 13 May 2026 and was lowest at ₹0 on 7 May 2026. In the last 4 days it fell by ₹5.
From one recorded day to the next, the GMP rose on 7 days, fell on 2 days and held on 3 days. The largest one-day move was a fall of ₹10 on 14 May 2026.
On the day bidding opened, 12 May 2026, the GMP was ₹18; on the day it closed, 14 May 2026, it was ₹15.
Bidding closed with the issue subscribed 840.74× overall.
At the ₹43 upper band, the last GMP pointed to a 34.88% gain; the shares listed up 38.95%, so the GMP understated the gain.
One lot is 3000 shares, ₹1,29,000 at the ₹43 upper band. On this SME issue an individual applies for at least 2 lots, ₹2,58,000.
The last GMP pointed to a gain of ₹45,000 on one lot. The shares listed at about ₹59.75, which made a gain of ₹50,246 on one lot.
At the highest GMP, ₹25, the figure for one lot was a gain of ₹75,000; at the lowest, ₹0, it was no gain.
GMP last updated: 19 May 2026, 9:31 AM IST
| Date | GMP | Over issue price | Implied listing | Change |
|---|---|---|---|---|
| 19 May 2026 | ₹15 | 34.88% | ₹58 | – |
| 18 May 2026 | ₹15 | 34.88% | ₹58 | −₹5 |
| 17 May 2026 | ₹20 | 46.51% | ₹63 | – |
| 16 May 2026 | ₹20 | 46.51% | ₹63 | – |
| 15 May 2026 | ₹20 | 46.51% | ₹63 | +₹5 |
| 14 May 2026 | ₹15 | 34.88% | ₹58 | −₹10 |
| 13 May 2026 | ₹25 | 58.14% | ₹68 | +₹7 |
| 12 May 2026 | ₹18 | 41.86% | ₹61 | +₹1 |
| 11 May 2026 | ₹17 | 39.53% | ₹60 | +₹1 |
| 10 May 2026 | ₹16 | 37.21% | ₹59 | +₹1 |
| 9 May 2026 | ₹15 | 34.88% | ₹58 | +₹7 |
| 8 May 2026 | ₹8 | 18.6% | ₹51 | +₹8 |
| 7 May 2026 | ₹0 | 0% | ₹43 | – |
GMP is an unofficial price from the grey market before the shares list. It is not a guarantee of the listing price and can move sharply from one day to the next. Read how we collect it in our methodology.